<DOC>
	<DOCNO>NCT00456560</DOCNO>
	<brief_summary>The purpose study evaluate effect paroxetine fluvoxamine way body distribute , breakdowns eliminates AV650 . In addition , information side effect may occur also collect .</brief_summary>
	<brief_title>AV650 Drug-Drug Interaction Study</brief_title>
	<detailed_description />
	<mesh_term>Paroxetine</mesh_term>
	<mesh_term>Fluvoxamine</mesh_term>
	<criteria>BMI 18.5 29.9 kg/m2 In good health , determine clinically significant finding medical history , 12lead ECG , vital sign Clinical laboratory evaluation within reference range test laboratory Negative test select drug abuse Screening Negative HBsAg HIV antibody screen Females childbearing potential must surgically sterile , postmenopausal least one year , use effective method contraception ; female child bear potential must negative serum pregnancy test Screening Day 1 Males must either sterile agree use approve method contraception Able comprehend willing sign Informed Consent Form History clinical manifestation significant metabolic , hepatic , renal , hematological , pulmonary , cardiovascular , endocrine , gastrointestinal , urological , neurological , psychiatric disorder , cancer History inflammatory arthritis History symptomatic hypotension History severe physical injury , direct impact trauma , neurological trauma within 6 month History seizure disorder History bipolar major depressive disorder History hypersensitivity allergy drug compound Known intolerance benzodiazepine Known intolerance active and/or inactive ingredient fluvoxamine paroxetine History stomach intestinal surgery resection , except appendectomy , hernia repair , and/or cholecystectomy allow History presence abnormal ECG History alcoholism , drug abuse , drug addiction Use nicotinecontaining nicotinereplacement product within 6 month Day 1 Participation investigational study drug trial within 90 day Day 1 Use prescription medications/products within 3 month Day 1 unless deem acceptable PI Received vaccination immunization within 1 month Day 1 Use overthecounter , nonprescription preparation within 7 day Day 1 Use alcoholcontaining , grapefruitcontaining , caffeinecontaining food beverages 72 hour Day 1 Poor peripheral venous access Donation blood within 3 month Day 1 plasma within 2 week Screening Receipt blood product within 2 month Day 1 Female subject pregnant nursing Any acute chronic condition , opinion PI , would limit subject 's ability complete and/or participate clinical study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2007</verification_date>
</DOC>